<?xml version="1.0"?>
<?xml-stylesheet type='text/xsl' href='../../ld1.xsl'?>
<LOBBYINGDISCLOSURE1>
   <imported>N</imported>
   <pages>2</pages>
   <regType>2</regType>
   <organizationName>Sidley Austin LLP</organizationName>
   <prefix></prefix>
   <firstName></firstName>
   <lastName></lastName>
   <address1>1501 K Street</address1>
   <address2></address2>
   <city>Washington</city>
   <state>DC</state>
   <zip>20005</zip>
   <zipext></zipext>
   <country>USA</country>
   <principal_city></principal_city>
   <principal_state></principal_state>
   <principal_zip></principal_zip>
   <principal_zipext></principal_zipext>
   <principal_country></principal_country>
   <registrantGeneralDescription>Law firm</registrantGeneralDescription>
   <selfSelect>N</selfSelect>
   <clientName>Mallinckrodt Pharmaceuticals</clientName>
   <clientAddress>675 McDonnell Blvd.</clientAddress>
   <clientCity>Hazelwood</clientCity>
   <clientState>MO</clientState>
   <clientZip>63042</clientZip>
   <clientZipExt></clientZipExt>
   <clientCountry>USA</clientCountry>
   <prinClientCity></prinClientCity>
   <prinClientState></prinClientState>
   <prinClientZip></prinClientZip>
   <prinClientZipExt></prinClientZipExt>
   <prinClientCountry></prinClientCountry>
   <clientGeneralDescription>Pharmaceutical producer</clientGeneralDescription>
   <senateID>35230</senateID>
   <houseID>312040144</houseID>
   <lobbyists>
      <lobbyist>
         <lobbyistFirstName>William</lobbyistFirstName>
         <lobbyistLastName>Sarraille</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>N/A</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Elizabeth</lobbyistFirstName>
         <lobbyistLastName>Kolbe</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Intern; Sen. John Kerry</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Andrew</lobbyistFirstName>
         <lobbyistLastName>Shoyer</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Assistent General Counsel, USTR</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Andrew</lobbyistFirstName>
         <lobbyistLastName>Shoyer</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Legal Advisor, U.S. Mission to the WTO</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName></lobbyistFirstName>
         <lobbyistLastName></lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition></coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
   </lobbyists>
   <alis>
      <ali_Code>PHA</ali_Code>
      <ali_Code>ENG</ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
   </alis>
   <specific_issues>Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99) sufficient to manufacture the Tc-99m generator medical-imaging radiopharmaceutical product</specific_issues>
   <affiliatedUrl></affiliatedUrl>
   <affiliatedOrgs>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
   </affiliatedOrgs>
   <foreignEntities>
      <foreignEntity>
         <name>Mallinckrodt plc</name>
         <address>Damastown Industrial Estate</address>
         <city>Mulhuddart, Dublin</city>
         <state></state>
         <country>IRL</country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution>0.00</contribution>
         <ownership_Percentage>100</ownership_Percentage>
      </foreignEntity>
      <foreignEntity>
         <name></name>
         <address></address>
         <city></city>
         <state></state>
         <country></country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution></contribution>
         <ownership_Percentage></ownership_Percentage>
      </foreignEntity>
   </foreignEntities>
   <reportYear>2014</reportYear>
   <reportType>RR</reportType>
   <effectiveDate>01/02/2014</effectiveDate>
   <printedName>William A. Sarraille, Partner</printedName>
   <signedDate>01/23/2014</signedDate>
</LOBBYINGDISCLOSURE1>